topotecan has been researched along with beta-lapachone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Crumpacker, CS; Dezube, BJ; Li, CJ; Pardee, AB; Zhang, LJ | 1 |
Kameoka, M; Nakamichi, K; Nukuzuma, C; Nukuzuma, S; Sugiura, S; Takegami, T; Tasaki, T | 2 |
3 other study(ies) available for topotecan and beta-lapachone
Article | Year |
---|---|
Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication.
Topics: Acute Disease; Antiviral Agents; Camptothecin; Cells, Cultured; Chronic Disease; Curcumin; Gene Expression Regulation, Viral; HIV Infections; HIV Long Terminal Repeat; HIV-1; In Vitro Techniques; Naphthoquinones; RNA, Viral; Topotecan; Virus Replication | 1993 |
Suppressive effect of topoisomerase inhibitors on JC polyomavirus propagation in human neuroblastoma cells.
Topics: Antiviral Agents; Cell Line; Cell Proliferation; DNA Replication; DNA, Viral; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Naphthoquinones; Neuroblastoma; Topoisomerase I Inhibitors; Topoisomerase Inhibitors; Topotecan; Virus Replication | 2016 |
CPT11 prevents virus replication in JCI cells persistently infected with JC polyomavirus.
Topics: Antiviral Agents; Camptothecin; Cell Line; Cell Proliferation; DNA Replication; DNA, Viral; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; JC Virus; Leukoencephalopathy, Progressive Multifocal; Naphthoquinones; Real-Time Polymerase Chain Reaction; Topoisomerase I Inhibitors; Topotecan; Viral Proteins; Virus Replication | 2017 |